Akèy › Leksemi mieloïd egi
Etid klinik pou Leksemi mieloïd egi ap rekrite nan Etazini
277 etid pou Leksemi mieloïd egi ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX86 etid
- New York City, NY51 etid
- Boston, MA45 etid
- Baldwin Park, CA40 etid
- Seattle, WA40 etid
- Columbus, OH34 etid
- Philadelphia, PA34 etid
- Durham, NC33 etid
- Tampa, FL29 etid
- Atlanta, GA29 etid
- Chicago, IL27 etid
- Portland, OR25 etid
- Washington, DC24 etid
- Miami, FL24 etid
- Los Angeles, CA24 etid
- St. Louis, MO23 etid
- Nashville, TN21 etid
- Dallas, TX21 etid
- Queens, NY21 etid
- Edison, NJ21 etid
- Birmingham, AL21 etid
- Cleveland, OH20 etid
- Cincinnati, OH20 etid
- Minneapolis, MN20 etid
- Mountain View, CA19 etid
- Buffalo, NY19 etid
- New Haven, CT19 etid
- Baltimore, MD19 etid
- Greenburgh, NY18 etid
- Winston-Salem, NC18 etid
- Pittsburgh, PA18 etid
- Salt Lake City, UT17 etid
- Ann Arbor, MI17 etid
- Milwaukee, WI17 etid
- Charlotte, NC16 etid
- Aurora, CO16 etid
- Rochester, NY16 etid
- Cedar Rapids, IA16 etid
- Charlottesville, VA16 etid
- Madison, WI16 etid
Pa eta
- Alabama21 etid
- Arizona22 etid
- Arkansas13 etid
- Ayiti7 etid
- Colorado22 etid
- Connecticut19 etid
- Delaware7 etid
- Distrik Columbia10 etid
- Florid55 etid
- Georgia37 etid
- Idaho9 etid
- Illinois32 etid
- Indiana14 etid
- Iowa17 etid
- Kalifòni79 etid
- Kansas20 etid
- Kentucky14 etid
- Lwizyàn13 etid
- Main9 etid
- Maryland31 etid
- Massachusetts46 etid
- Michigan24 etid
- Minnesota27 etid
- Mississippi8 etid
- Missouri24 etid
- Montana6 etid
- Nebraska10 etid
- Nevada9 etid
- New Hampshire9 etid
- New Jersey33 etid
- New Mexico9 etid
- New York71 etid
- North Carolina43 etid
- North Dakota4 etid
- Ohio56 etid
- Oklahoma14 etid
- Oregon27 etid
- Pennsylvania45 etid
- Rhode Island11 etid
- South Carolina16 etid
- South Dakota6 etid
- Tennessee31 etid
- Texas95 etid
- Utah17 etid
- Vermont7 etid
- Virginia24 etid
- Washington41 etid
- West Virginia6 etid
- Wisconsin25 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
Laj 60 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07437950Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou Sep 30, 2026 · NCT06904066A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Ap rekriteFaz 1
Laj 12 a 78 · Tout sèks · Mizajou Sep 29, 2026 · NCT03802695A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06763341Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
Laj 18 a 59 · Tout sèks · Mizajou Sep 28, 2026 · NCT05554393Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06484062A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06852222MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05564390Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT03629171A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06548230Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07211958Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06871410Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT03661307Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06398457Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT03874052A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 12 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT05360160A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07581002A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
Ap rekriteFaz 1
Jiska laj 21 · Tout sèks · Mizajou Sep 23, 2026 · NCT07012044Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06672146A Study of CRD3874-SI in People With Leukemia
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07661095Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06317649Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
Laj 18 a 59 · Tout sèks · Mizajou Sep 22, 2026 · NCT05554406Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07710534Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06769490A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06284486Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.